Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Hospitale s.r.o.

Slovakia Hontianska Cesta 996/49, 936 01 Sahy, Slovakia

  • 2 trials recruiting
  • Heart failure with preserved ejection fraction
  • Adult patients

About Specializations

Hospitale s.r.o. in Sahy, Slovakia specialises in clinical trials of conditions such as Heart failure with preserved ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The Interné oddelenie at Hospitale s.r.o. in Sahy, Slovakia, is concentrating on heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF). Current studies aim to test whether novel agents can lower the risk of cardiovascular death and hospitalizations in these patients.

  • Testing the mineralocorticoid receptor antagonist finerenone for reduction of heart‑failure events
  • Evaluating the glucose‑linked compound elecoglipron on cardiovascular outcomes
  • Analyzing outcomes in participants already receiving SGLT2‑inhibitor therapy

With two active trials and a dedicated investigator, the department seeks to improve treatment options for chronic heart‑failure conditions and advance cardiovascular care in Central Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hontianska Cesta 996/49936 01 SahySlovakia
Open in maps ↗
Recruiting now
2 trials
Conditions studied
1

More sites in SahySlovakia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Heart failure with preserved ejection fraction

Recruiting
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.